News
MGH Psychiatry Faculty To Direct 2023 Substance Use Disorder Conference
The MGH Psychiatry Academy faculty invite you to join us at Disney’s Grand Floridian Resort & Spa for our annual Substance Use Disorder conference, held on February 19, 2023 to February 22, 2023. Substance use disorders are complex and have a huge impact on patients, families and communities. They challenge even experienced health care professionals…MORE
Publication Alert: Trial Assessing Provider Education and Community Health Worker Support for Tobacco Cessation
Psychiatric Services recently published results from CAM Director Dr. Eden Evins’s randomized clinical trial, finding that provider education (PE) and community health worker (CHW) support increased tobacco abstinence rates among adults with serious mental illness. The analysis found that community health workers, acting as community-based supports for people with serious mental illness and their physicians,…MORE
Tobacco and Substance Use Disorder Training at MGH/HMS
Massachusetts General Hospital (MGH) and Harvard Medical School (HMS) offer an internship in Clinical Psychology to doctoral students in clinical, counseling, or school psychology programs. As a supplemental and optional training opportunity, interested individuals, in consult with their primary track mentors, can select from various substance use disorder (SUD) training opportunities (e.g., didactics, clinical service,…MORE
Dr. Jodi Gilman to Speak at 23rd International Council on Alcohol, Drugs and Traffic Safety (ICADTS) Conference
CAM Director of Neuroscience Dr. Jodi Gilman will be a keynote speaker at the 23rd International Council on Alcohol, Drugs and Traffic Safety (ICADTS) Conference, which will take place on August 28-31, 2022, in De Doelen, Rotterdam, The Netherlands. The conference brings together delegates from the areas of public health and safety, traffic, and transport psychology, public health,…MORE
CAM Medical Marijuana Study Receives Widespread News Coverage
CAM Director of Neuroscience Dr. Jodi Gilman’s medical marijuana study, which was published in JAMA Network Open, has received news coverage in 43 different outlets, ranging from the Boston Herald to U.S. News. The study found that acquisition of a medical marijuana card increased the incidence and severity of cannabis use disorder (CUD) and resulted in no significant…MORE
Upcoming Science of Addiction Panel
The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School will be hosting a virtual panel discussion, The Science of Addiction, on May 17, 2022 at 12pm. At the panel, CAM Founding Director, Eden Evins, M.D., will discuss addiction neuroscience, prognosis, and treatment. Then, Stephanie Tabashneck, Psy.D., J.D., will lead a discussion on the role…MORE
Three CAM Postdoctoral Fellows Honored With Travel Awards to CPDD
Three CAM postdoctoral fellows – Megan Cooke, Joanna Streck, and Brenden Tervo-Clemmens – are all recipients of the College on Problems of Drug Dependence’s Travel Awards for 2022. CPDD Travel Awards are given to early career investigators to attend the CPDD Annual Scientific Meeting. Congratulations to the winners!
DMH Research Centers of Excellence to Hold 2022 Conference
The MGH Center of Excellence together with the UMASS iSPARC Center of Excellence is excited to announce that the DMH Research Centers of Excellence conference will be held on Monday, May 9th, 2022 from 12:30 PM – 4:30 PM. The theme is In This Together…But Not in the Same Boat: How we are supporting youth, young adults, and families…MORE
CAM Medical Marijuana Study Featured on CNN
On Saturday, March 19, CNN published an article featuring CAM Director of Neuroscience Dr. Jodi Gilman’s medical marijuana study, which found that acquisition of a medical marijuana card increased the incidence and severity of cannabis use disorder (CUD) and resulted in no significant improvement in pain, anxiety, or depressive symptoms. Read the full article at this…MORE
CAM fNIRS Study Featured on Boston Globe’s Front Page
The Boston Globe’s front page on February 5, 2022 featured CAM Founding Director Dr. Eden Evins’s and Director of Neuroscience Dr. Jodi Gilman’s efforts to develop a device to reliably detect marijuana impairment. The device uses functional near-infrared spectroscopy, or fNIRS, to look into the brain using light-based imaging. Because the brain looks different when an individual is…MORE